undamentalytics Newsletter
Sign in

Natures Sunshine Products Inc (NATR) stock

Add to watchlist

Add holding +

NASDAQ: NATR Nasdaq Personal Care Products Next results ~November 4, 2026

C+ Fundamentals grade

Natures Sunshine Products Inc is a US-listed company in the personal care products industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

~$20

Cash-flow model

Base case. Range ~$16–$25 across our lower- and higher-growth cases (0.6%–10.6% a year).

Price vs value

Undervalued

The price is below our entire value range; our base value is 68% above it.

Price used: $12.08, November 3, 2026

Natures Sunshine Products Inc valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders2 buying, 5 selling14 purchases and 12 sales by directors and officers, last 12 monthsInsider trades
  • Funds68 adding, 70 cuttingOf 33 active managers that changed their stake, 21 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Natures Sunshine Products files

Where Natures Sunshine Products stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $492m, up 6.8% on a year earlier, about the same pace as a quarter earlier. That growth ranks 3 of 12 among the personal care products companies we cover. Free-cash-flow margin fell to 3.7% from 4.9% a year earlier. The diluted share count is down 4.6% on a year earlier, which lifts each remaining share. Against its peers on growth, profitability, cash generation and balance sheet, it grades B. It passes 3 of our 3 financial-health checks. Our cash-flow model value is $19.73 a share, against a share price of $12.31. At that price, our model says the market is pricing in cash flow shrinking about 6.0% a year for five years, slower than the 2.1% a year revenue growth it has delivered.

Source: 10-Q filed August 6, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 4, 2026 (estimated)

Natures Sunshine Products Inc's trailing-twelve-month revenue grew 6.8% year on year, with a free-cash-flow margin of 3.7%. Where it stands out: days sales outstanding of 10 days ranks 3 of 14 personal care products companies we cover.

Our discounted-cash-flow model values the business at ~$20 per share in the base case (~$16–$25 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow fell 19.1% while net income grew 28.3%: a 47pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Priced below our value. The share price of $12.02 is 69% below our value per share of $20.
  • Shrinking share count. Diluted shares fell 4.6% in a year, so each share owns more of the business.
  • Net cash. Cash exceeds long-term debt by $0.1bn.

Things to watch

  • Results due soon. Results are expected around 5 November; the share price can move sharply on the day.
  • Volatile shares. Over the past year the shares showed annualised volatility of 50% and a beta of 0.4 against the S&P 500.
  • Estimates being cut. Analysts' consensus for next year's earnings per share has fallen 9.2% over 90 days.

Latest results: FY2026 Q2

Filed August 6, 2026
Earnings per share
$0.21 against an average estimate of $0.27: missed by 22.2%
Revenue
$117m, up 1.9% on a year earlier
Share reaction
-18.3% in the first session after the results on August 6, 2026, against +0.5% for the S&P 500
Next report
November 4, 2026; average EPS estimate $0.27

Natures Sunshine Products' figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+0.5%
  • 1 week-2.5%
  • 1 month-3.0%
  • This year-44.3%
  • 1 year-12.2%
  • 5 years-23.7%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$492M
Operating margin
6.0%
Net margin
3.7%
EPS (TTM, diluted)
$1.00

Growth

Revenue growth
+6.8%
Change in growth rate
−0.5 pts
Share count change
−4.6%

Cash

Free cash flow (TTM)
$18.1M
FCF margin
3.7%
Stock pay % of revenue
1.3%

Earnings

Last results
August 6, 2026
Next results (est.)
November 5, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Insider trade
  2. Results

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Natures Sunshine Products Inc valuation models and calculator

What the price is pricing in

The share price implies cash flow shrinking about 7.5% a year for five years.That is slower than the 2.1% a year revenue growth Natures Sunshine Products has delivered.

  • Priced in-7.5%
  • Last 12 months6.8%
  • 3 years a year4.4%
  • 5 years a year2.1%

Our cash-flow model with every input fixed except growth over the next five years, solved for the growth at which the model value equals the share price ($12.09, Nov 3, 2026). Cash-flow growth then fades to 2.5% a year; discount rate 8.5%. Delivered figures are revenue growth from SEC filings. This is a model exercise, not investment advice or a forecast of the share price. All companies

Fundamentalytics rating

model v1.6 · 2026-11-03
Buy12-month view
12-month price target
~$20
Price used
$12.09close November 3, 2026
Implied change
▲ +68%
Uncertainty
Low

How we got here: a discounted-cash-flow model of Natures Sunshine Products Inc's free cash flow after stock-based pay with after-tax interest added back ($13.7M, FY2026 Q2 TTM), growing 4.2% and 5.4% in the next two years (forecasts, guidance and its record), then back to 5.6% by year five, and fading to 2.5%, discounted at 8.5%. Lower and higher growth cases span ~$16–~$25 ; that spread sets a 15% margin before we rate Buy or Sell.

Produced by Fundamentalytics' automated valuation model on November 3, 2026, using delayed market prices. Rating meanings, methodology and conflicts: recommendations disclosure and research disclaimer. General research, not personal advice — it does not consider your circumstances. Prices can fall as well as rise.

Our value per share comes from a discounted-cash-flow model of Natures Sunshine Products Inc's free cash flow after stock-based pay ( $13.7M, FY2026 Q2 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation models

We value Natures Sunshine Products Inc as an operating company, with every model that fits that kind of business. Cost of equity 7.6%: the 10-year Treasury yield (4.9%) plus a beta of 0.6 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Cash-flow model (DCF) Free cash flow to the firm (after stock pay, with after-tax interest added back), grown then faded to 2.5%, discounted at 8.5% as the firm rate, less debt and other claims. ~$20 ~$16–$25 Primary model, counts double
Price-to-earnings vs peers Earnings per share times peers' typical (harmonic-mean) price-to-earnings. ~$13 ~$9.4–$23 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$11 ~$7.7–$17 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$12 ~$10–$16 Included
Combined value Weighted average of the models that apply: the primary model (cash-flow model (dcf)) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$15 ~$11–$20 4 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Natures Sunshine Products Inc with Personal Care Products in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

What moves the value

  • Revenue growth 5 points lower ▼ −21%
  • Revenue growth 5 points higher ▲ +27%
  • Free-cash-flow margin 1 point lower ▼ −22%
  • Last year's free-cash-flow margin change, if it persists ▼ −21%
  • Discount rate 1 point higher ▼ −12%
Value per share under different assumptions
Discount rate ↓ / growth → −5% growth0% growth5% growth10% growth15% growth20% growth
7% $16$20$25$32$41$53
8.5% $13$16$20$25$32$40
10% $12$14$17$21$26$32

Valuation multiples over time Market data may be delayed

At fiscal year end 20152016201720182019202020212022202320242025Now
Share price$9.15$14.07$10.94$7.72$8.46$14.16$18.50$8.32$17.29$14.66$21.58$12.02
Market value$175m$268m$207m$148m$166m$283m$376m$161m$337m$280m$399m$217m
+ Net debt (− = net cash)−$36m−$12m−$30m−$51m−$54m−$88m−$84m−$58m−$82m−$85m−$94m−$83m
Enterprise value$139m$256m$177m$97m$113m$194m$292m$103m$254m$195m$305m$135m
Multiples
Price / sales 0.5x0.8x0.6x0.4x0.5x0.7x0.8x0.4x0.8x0.6x0.8x0.4x
Price / earnings 11.9x125.3x——24.6x13.3x13.0x—22.3x36.4x20.4x12.0x
Price / free cash flow ——41.1x8.7x48.3x8.6x13.5x—10.9x19.5x13.8x12.0x
EV / EBITDA 7.6x17.2x17.6x6.4x4.2x6.0x6.4x3.8x8.3x5.7x7.9x3.2x

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

68 /100

Moderate moat

How hard Natures Sunshine Products's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 20 / 20

    Cash operating profit has been a median 63.8% of total assets over 10 years.

  • Pricing power 20 / 20

    Gross margin has been a median 73.2%, moving by 0.9 percentage points (standard deviation) across 10 years.

  • Durability 2 / 20

    Operating margin has been a median 4.7%; its worst year was 0.7%.

  • Cash conversion 11 / 20

    Free cash flow was positive in 9 of 10 years, at a median 4.0% of revenue.

  • Discipline 20 / 20

    The diluted share count fell 11.0% over five years; stock-based pay has been a median 1.0% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (73 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 4, 2026, after the close. Analysts expect revenue of $130m and EPS of $0.27 (range $0.21 to $0.32) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $1.08 −14% $496m +3%
Next $1.23 +14% $519m +5%

Next year's EPS estimate has moved −9.2% in 90 days, across 2 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is −10.4% on 90 days ago. In the last 30 days, 0 analysts raised Natures Sunshine Products Inc's forecast and 1 cut it.

Consensus EPS forecast Natures Sunshine Products Inc, last 90 days
$1.00 $1.10 $1.20 $1.30 $1.40 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $1.21 Current fiscal year, 60 days ago: $1.21 Current fiscal year, 30 days ago: $1.21 Current fiscal year, 7 days ago: $1.18 Current fiscal year, Now: $1.08 $1.08 Next fiscal year, 90 days ago: $1.35 Next fiscal year, 60 days ago: $1.35 Next fiscal year, 30 days ago: $1.35 Next fiscal year, 7 days ago: $1.32 Next fiscal year, Now: $1.23 $1.23

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $1.21$1.35
60 days ago $1.21$1.35
30 days ago $1.21$1.35
7 days ago $1.18$1.32
Now $1.08$1.23

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 $0.27 $0.21 −22.2%
Mar 2026 $0.20 $0.30 +46.3%
Dec 2025 $0.18 $0.30 +62.2%
Sept 2025 $0.16 $0.36 +125.0%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, August 6, 2026

No numeric guidance in Natures Sunshine Products Inc's latest earnings release (filed August 6, 2026). Some companies give their outlook only on the earnings call.

How our valuation uses these forecasts

Our cash-flow model grows Natures Sunshine Products Inc's revenue by +4.2% next year and +5.4% the year after, then fades back toward its own record by year five. Next year's rate weighs analysts' consensus (+3.1%, weight 56%) and the company's own record (+5.6%, weight 44%) . How the weights are set.

Analyst recommendations

2 analysts, Oct 2026
Buy2100%
Hold00%
Sell00%

Monthly trend

  1. Oct 202622
  2. Sep 202622

Counts of recommendations published by analysts covering Natures Sunshine Products Inc, by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
7.2%
of tradable shares
Days to cover
7.98
at average volume
Short interest, 1 month
+11%
to October 15, 2026
Held by institutions
94%
of shares
Held by insiders
3.5%
of shares
Employees
806
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −10.8%

$13.48 on October 31, 2025 to $12.02

ThenNowEffect
Revenue (last 12 months) $461m $492m +6.8%
Net margin 3.1% 3.7% +20.2%
P/E multiple 18.1x 12.0x −33.7%
Share count 19m 18m +4.8%

Biggest factor: p/e multiple.

Last 3 years −33.1%

$17.96 on November 3, 2023 to $12.02

ThenNowEffect
Revenue (last 12 months) $432m $492m +13.8%
Net margin 1.2% 3.7% +198.6%
P/E multiple 65.2x 12.0x −81.6%
Share count 19m 18m +6.9%

Biggest factor: p/e multiple.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
NATR+31%−55%+108%−15%+47%−44%
Industry peers (median)+32%−32%+3%−8%−34%+1%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
NATR67%17%75%42%42%36%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
NATR−33%−58%−24%−44%−25%−57%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since November 2, 2015: 62% from October 12, 2016 to March 18, 2020. Getting back needed a 163% gain, reached on January 6, 2021, 294 days after the low.

Price behaviour

52-week range
$12.02 – $27.80
From 52-week high
−56.8%
vs 50-day average
−7.7%
vs 200-day average
−41.4%
Volatility (1 year)
50%
Beta vs S&P 500
0.38

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
5 up, 7 down
typical move ±12.0%
After a week
5 up, 7 down
typical move ±14.5%
After a month
6 up, 6 down
typical move ±18.7%
Results releasedNext dayS&P 500 next day5 days21 days
August 6, 2026 −18.3% +0.5% −23.7% −30.1%
May 7, 2026 −7.7% +0.5% −15.1% −24.7%
March 10, 2026 −1.5% −0.3% −4.5% +7.6%
November 6, 2025 +26.8% −1.0% +46.8% +48.0%
July 31, 2025 +9.6% −2.0% +6.5% +16.9%
March 12, 2025 −7.2% −0.8% −10.1% −19.3%
November 7, 2024 +4.8% +1.2% +12.5% +12.9%
August 9, 2024 −19.6% +0.5% −10.6% −10.7%
May 8, 2024 −18.3% +0.6% −17.6% −21.3%
March 12, 2024 +15.4% +0.9% +13.2% +12.2%
November 7, 2023 −2.0% +0.4% −1.9% −5.1%
August 10, 2023 +13.3% 0.0% +11.1% +16.0%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Natures Sunshine Products Inc in five measures

Fundamentals grade C+
Growth Profitability Cash Balance sheet Value

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Natures Sunshine Products Inc
$420M $440M $460M $480M $500M FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $439.1M Revenue (TTM), FY23 Q4: $445.3M Revenue (TTM), FY24 Q1: $447.7M Revenue (TTM), FY24 Q2: $441.7M Revenue (TTM), FY24 Q3: $445.1M Revenue (TTM), FY24 Q4: $454.4M Revenue (TTM), FY25 Q1: $456.6M Revenue (TTM), FY25 Q2: $460.8M Revenue (TTM), FY25 Q3: $474.5M Revenue (TTM), FY25 Q4: $480.1M Revenue (TTM), FY26 Q1: $489.8M Revenue (TTM), FY26 Q2: $492M $492M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $439.1M
FY23 Q4 $445.3M
FY24 Q1 $447.7M
FY24 Q2 $441.7M
FY24 Q3 $445.1M
FY24 Q4 $454.4M
FY25 Q1 $456.6M
FY25 Q2 $460.8M
FY25 Q3 $474.5M
FY25 Q4 $480.1M
FY26 Q1 $489.8M
FY26 Q2 $492M
Revenue growth, TTM YoY Natures Sunshine Products Inc
0% 2% 4% 6% 8% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: 0.5% Revenue growth, TTM YoY, FY23 Q4: 5.5% Revenue growth, TTM YoY, FY24 Q1: 6.6% Revenue growth, TTM YoY, FY24 Q2: 2.1% Revenue growth, TTM YoY, FY24 Q3: 1.4% Revenue growth, TTM YoY, FY24 Q4: 2.0% Revenue growth, TTM YoY, FY25 Q1: 2.0% Revenue growth, TTM YoY, FY25 Q2: 4.3% Revenue growth, TTM YoY, FY25 Q3: 6.6% Revenue growth, TTM YoY, FY25 Q4: 5.7% Revenue growth, TTM YoY, FY26 Q1: 7.3% Revenue growth, TTM YoY, FY26 Q2: 6.8% 6.8%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 0.5%
FY23 Q4 5.5%
FY24 Q1 6.6%
FY24 Q2 2.1%
FY24 Q3 1.4%
FY24 Q4 2.0%
FY25 Q1 2.0%
FY25 Q2 4.3%
FY25 Q3 6.6%
FY25 Q4 5.7%
FY26 Q1 7.3%
FY26 Q2 6.8%
Operating margin (TTM) Natures Sunshine Products Inc
3% 4% 5% 6% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: 3.9% Operating margin (TTM), FY23 Q4: 4.2% Operating margin (TTM), FY24 Q1: 5.2% Operating margin (TTM), FY24 Q2: 4.9% Operating margin (TTM), FY24 Q3: 4.8% Operating margin (TTM), FY24 Q4: 4.4% Operating margin (TTM), FY25 Q1: 4.7% Operating margin (TTM), FY25 Q2: 4.4% Operating margin (TTM), FY25 Q3: 5.1% Operating margin (TTM), FY25 Q4: 5.2% Operating margin (TTM), FY26 Q1: 5.7% Operating margin (TTM), FY26 Q2: 6.0% 6.0%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 3.9%
FY23 Q4 4.2%
FY24 Q1 5.2%
FY24 Q2 4.9%
FY24 Q3 4.8%
FY24 Q4 4.4%
FY25 Q1 4.7%
FY25 Q2 4.4%
FY25 Q3 5.1%
FY25 Q4 5.2%
FY26 Q1 5.7%
FY26 Q2 6.0%
FCF margin (TTM) Natures Sunshine Products Inc
2% 4% 6% 8% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: 5.3% FCF margin (TTM), FY23 Q4: 6.9% FCF margin (TTM), FY24 Q1: 5.0% FCF margin (TTM), FY24 Q2: 3.3% FCF margin (TTM), FY24 Q3: 2.9% FCF margin (TTM), FY24 Q4: 3.2% FCF margin (TTM), FY25 Q1: 3.8% FCF margin (TTM), FY25 Q2: 4.9% FCF margin (TTM), FY25 Q3: 6.6% FCF margin (TTM), FY25 Q4: 6.0% FCF margin (TTM), FY26 Q1: 4.7% FCF margin (TTM), FY26 Q2: 3.7% 3.7%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 5.3%
FY23 Q4 6.9%
FY24 Q1 5.0%
FY24 Q2 3.3%
FY24 Q3 2.9%
FY24 Q4 3.2%
FY25 Q1 3.8%
FY25 Q2 4.9%
FY25 Q3 6.6%
FY25 Q4 6.0%
FY26 Q1 4.7%
FY26 Q2 3.7%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-K/A, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Where the money goes

FY2025, from the 10-K

Each dollar Natures Sunshine Products took in during FY2025, followed through to profit: what it cost to make, what went on running the business, and what was left after tax.

  1. Revenue $480M
  2. Other income $4.1M · 0.9%
  3. Cost of revenue $132M · 27.6%
  4. Gross profit $348M · 72.4%
  5. Selling, general and admin $178M · 37.2%
  6. Other operating costs $143M · 29.7%
  7. Operating income $24.7M · 5.2%
  8. Income tax $9.4M · 1.9%
  9. Net income $19.5M · 4.1%

Shares of revenue. Source: Natures Sunshine Products's 10-K for FY2025, as filed with the SEC. "Other" lines are what the reported lines leave unexplained. Other income is income outside operations, such as investment gains.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2009 Dec 2009 2010 Dec 2010 2011 Dec 2011 2012 Dec 2012 2013 Dec 2013 2014 Dec 2014 2015 Dec 2015 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 342 350 368 361 370 366 325 341 342 365 362 385 444 422 445 454 480 492
Gross profit 274 261 278 269 277 275 239 250 251 269 268 284 329 300 321 325 348 360
EBITDA 17 16 25 38 28 23 18 15 10 15 27 32 46 27 31 34 39 43
Operating income 12 11 20 34 24 19 14 10 1 5 16 21 35 16 19 20 25 29
Net income 6 −1 18 25 18 10 15 2 −13 −1 7 21 29 −0 15 8 20 18
Diluted EPS $0.39 −$0.08 $1.12 $1.59 $1.07 $0.56 $0.77 $0.11 −$0.69 −$0.04 $0.34 $1.07 $1.42 −$0.02 $0.77 $0.40 $1.06 $1.00
Growth (year on year)
Revenue — +2.3% +5.1% −1.9% +2.5% −0.9% −11.4% +5.1% +0.3% +6.7% −0.7% +6.3% +15.3% −5.0% +5.5% +2.0% +5.7% +6.8%
EBITDA — −8.4% +58.1% +54.7% −26.1% −16.4% −21.6% −19.3% −32.5% +51.3% +76.3% +20.6% +42.2% −40.5% +12.0% +12.3% +12.5% +22.5%
Operating income — −9.4% +79.0% +67.9% −30.4% −19.2% −27.2% −27.6% −86.2% — — +33.2% +61.4% −53.1% +15.3% +7.2% +23.1% +44.6%
Net income — — — +44.2% −30.6% −43.1% +46.6% −85.4% — — — — +35.2% −101.4% — −49.0% — +28.3%
Diluted EPS — — — +42.0% −32.7% −47.7% +37.5% −85.7% — — — — +32.7% −101.4% — −48.1% — +34.5%
Margins
Gross margin 80.0% 74.5% 75.7% 74.7% 75.0% 75.0% 73.7% 73.3% 73.4% 73.8% 74.1% 73.7% 74.0% 71.0% 72.1% 71.5% 72.4% 73.2%
EBITDA margin 4.9% 4.4% 6.7% 10.5% 7.6% 6.4% 5.7% 4.4% 2.9% 4.2% 7.4% 8.4% 10.3% 6.5% 6.9% 7.6% 8.0% 8.7%
Operating margin 3.6% 3.2% 5.5% 9.4% 6.4% 5.2% 4.3% 2.9% 0.4% 1.5% 4.5% 5.6% 7.8% 3.9% 4.2% 4.4% 5.2% 6.0%
Net margin 1.8% −0.4% 4.8% 7.0% 4.8% 2.7% 4.5% 0.6% −3.8% −0.2% 1.9% 5.5% 6.5% −0.1% 3.4% 1.7% 4.1% 3.7%
Free-cash-flow margin −0.7% 3.9% 0.4% 5.5% 5.6% −3.3% −3.8% −2.2% 1.5% 4.7% 0.9% 8.5% 6.3% −1.6% 6.9% 3.2% 6.0% 3.7%
Cash flow
Cash from operations 1 16 4 27 29 14 10 3 11 22 9 38 35 1 41 25 35 27
Capital spending 3 3 2 7 9 26 23 11 6 5 5 5 7 8 10 11 6 9
Free cash flow −2 14 1 20 21 −12 −12 −8 5 17 3 33 28 −7 31 14 29 18
Stock-based pay 0 0 3 3 3 4 4 3 2 2 2 4 4 3 5 5 6 6
Free cash flow after stock pay −3 13 −2 17 17 −16 −17 −11 3 15 1 29 24 −10 26 10 23 12
Balance sheet
Cash 36 48 59 79 77 59 41 32 43 51 54 92 86 60 82 85 94 83
Total debt 0 0 9 6 12 0 5 20 13 0 0 4 2 2 0 — 0 0
Net debt (negative = net cash) −36 −48 −50 −74 −65 −59 −36 −12 −30 −51 −54 −88 −84 −58 −82 −85 −94 −83
Diluted shares 16m 16m 16m 16m 16m 18m 19m 19m 19m 19m 20m 20m 20m 19m 19m 19m 18m 18m
Returned to shareholders
Dividends 1 — — 2 30 35 7 8 2 0 — 0 20 0 — — — —
Buybacks — — — — 3 7 7 0 0 — — 0 7 14 6 9 16 7
Total returned 1 — — 2 33 43 14 8 2 0 — 0 27 14 6 9 16 7

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

3 of 3 checks passed · June 30, 2026
What it owns · $260m
Short-term assets $178mLonger-term assets $81m
What it owes, and who funded it · $260m
Short-term liabilities $69mLonger-term liabilities $22mShareholders' equity $169m
  • Short-term assets cover short-term liabilities $178m of assets due within a year against $69m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $178m short-term assets against $22m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Operating income of $29m against $141,000 of interest.

From Natures Sunshine Products Inc's latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2026 Q2 TTM
Buybacks (TTM)
$6.5M
Buybacks, last 3 fiscal years
$31.6M
Diluted share count
−4.6%
year over year
Total shareholder yield
3.1%
dividends 0.0% + buybacks 3.1% of market value
Sales & admin spending
37.1%
of revenue
Days sales outstanding
10 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in personal care products
Last 12 months unless stated NATR HNST ODD USNA LFVN NUS Median
Revenue, last 12 months $492m $342m $810m $913m $183m $1.4bn $913m
Revenue growth, last 12 months 6.8% −12.3% 25.2% 1.6% −20.1% −15.4% 3.5%
Revenue growth, 3-year average 4.4% 0.8% — −1.2% −5.1% −12.3% −0.1%
Revenue growth, latest quarter 1.9% −10.9% — −5.3% −23.1% −17.1% 2.7%
Gross margin 73.2% 35.7% 72.7% 77.4% 77.6% 69.2% 69.2%
Operating margin 6.0% −4.4% 14.7% −0.1% 3.3% −0.8% 6.7%
Operating margin, 3-year average 5.1% −2.2% — 5.3% 3.6% −2.8% 5.5%
Net margin 3.7% −3.6% 13.7% −2.4% 2.8% −15.7% 3.4%
Cash from operations / revenue 5.6% 16.5% 10.8% 3.0% 5.6% 3.7% 9.9%
Free-cash-flow margin 3.7% 15.4% 10.3% 1.7% 3.7% 0.8% 9.6%
Free-cash-flow margin, 3-year average 4.0% 6.3% — 4.7% 4.4% 3.4% 6.0%
Stock pay / revenue 1.3% 3.2% 4.2% 1.6% 1.3% 1.0% 1.0%
Change in share count −4.6% 1.8% — −2.9% −2.2% 0.1% −0.0%

Median of all 21 companies we cover in personal care products. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

21 personal care products companies
Measure Company Peer median Rank
Revenue growth Growth 6.8% 3.5% 6 of 21
Change in growth rate Growth -0.5pp +0.7pp 13 of 21
Gross margin Profitability 73.2% 69.2% 8 of 21
Operating margin Profitability 6.0% 6.7% 12 of 21
Net margin Profitability 3.7% 3.4% 9 of 21
Free-cash-flow margin Cash generation 3.7% 9.6% 14 of 21
Stock pay as % of revenue Cash generation 1.3% 1.0% 12 of 18
Change in share count Balance sheet -4.6% -0.0% 4 of 19
Days sales outstanding Balance sheet 10 days 33 days 3 of 14

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Asia $222M 46.2% ▲ 6.7%
North America $144M 29.9% ▲ 3.4%
Europe $93.1M 19.4% ▲ 9.8%
Latin America and Other $21.6M 4.5% ▼ 5.5%
Products and services
Line of business Revenue Share YoY
General Health Products $192M 39.8% ▲ 4.5%
Digestive Products $124M 25.8% ▲ 11.3%
Cardiovascular Products $81.6M 16.9% ▼ 0.1%
Immunity Products $40.8M 8.5% ▲ 5.4%
Personal Care Products $23.3M 4.8% ▲ 30.7%
Weight Management Products $17.9M 3.7% ▼ 12.6%
Shipping and Handling $2.5M 0.5% ▲ 19.0%
Geography
Region Revenue Share YoY
Other Countries $173M 35.9% ▲ 7.5%
United States $133M 27.8% ▲ 4.3%
Taiwan $67.3M 14.0% ▼ 4.7%
Japan $56.1M 11.7% ▲ 27.6%
South Korea $50.8M 10.6% ▼ 1.0%

From Natures Sunshine Products Inc's 10-K filed March 10, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$346M
Institutions reporting
151
Shares held vs prior quarter
▲ 3.6%
Positions opened / closed
16 / 15

Top buyers and sellers, Q2 2026: 68 institutions bought and 70 sold ; the biggest buyer was Vanguard Portfolio Management LLC (+173K shares) and the biggest seller Sei Investments Co (−105K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Wynnefield Capital Inc $53.9M 2.5M 15.6% 0.0%
Prescott Group Capital Management, L.L.C. $38.9M 1.8M 11.2% 0.0%
Blackrock, Inc. $21.6M 989K 6.2% ▼ 7.1%
Dimensional Fund Advisors LP $20.1M 924K 5.8% ▲ 3.1%
American Century Companies Inc $15.6M 715K 4.5% ▲ 24.4%
Acadian Asset Management LLC $15M 688K 4.3% ▲ 4.5%
Kennedy Capital Management LLC $13.6M 624K 3.9% ▼ 9.8%
Vanguard Capital Management LLC $13.2M 604K 3.8% ▲ 1.3%
Renaissance Technologies LLC $11.5M 528K 3.3% ▼ 0.8%
Geode Capital Management, LLC $8.3M 380K 2.4% ▲ 2.0%
Punch & Associates Investment Management, Inc. $7.4M 340K 2.1% 0.0%
State Street Corp $7.1M 327K 2.1% ▲ 0.3%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Natures Sunshine Products Inc's complete shareholder register. Values are as reported by the filers ; 1 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $2.6M 14 trades by 2 insiders, last 12 months Insider sales History → $2.1M 12 trades by 5 insiders · 0% under pre-set plans
Net ▲ $518,108 net buying
Insider Date Trade Shares Price Value
Frohlich Phil 10% owner August 17, 2026 Buy 20,000 $14.69 $293,800
Prescott Group Capital Management, L.L.C. 10% owner August 10, 2026 Buy 876 $15.64 $13,701
Prescott Group Capital Management, L.L.C. 10% owner August 10, 2026 Buy 16,928 $15.80 $267,462
Prescott Group Capital Management, L.L.C. 10% owner August 10, 2026 Buy 13,072 $15.78 $206,276
Prescott Group Capital Management, L.L.C. 10% owner August 10, 2026 Buy 10,000 $16.01 $160,100
Prescott Group Capital Management, L.L.C. 10% owner August 7, 2026 Buy 10,000 $16.46 $164,600
Prescott Group Capital Management, L.L.C. 10% owner August 7, 2026 Buy 1,000 $16.48 $16,480
Prescott Group Capital Management, L.L.C. 10% owner August 7, 2026 Buy 20,000 $16.55 $331,000
Prescott Group Capital Management, L.L.C. 10% owner August 7, 2026 Buy 5,000 $16.62 $83,100
Prescott Group Capital Management, L.L.C. 10% owner August 7, 2026 Buy 30,000 $16.68 $500,400
Prescott Group Capital Management, L.L.C. 10% owner August 7, 2026 Buy 20,000 $16.69 $333,800
Prescott Group Capital Management, L.L.C. 10% owner August 7, 2026 Buy 10,000 $16.72 $167,200

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around November 5, 2026 estimated from the company's past filing pattern, not announced

  • August 6, 2026
  • May 7, 2026
  • March 10, 2026
  • November 6, 2025
  • July 31, 2025
  • March 12, 2025

Recent SEC filings

Data status

When each part of this page on Natures Sunshine Products Inc was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Natures Sunshine Products Inc in brief

What does Natures Sunshine Products Inc do?
Natures Sunshine Products Inc is a US-listed company in the personal care products industry. Its financial year ends in December.
What is Natures Sunshine Products Inc's stock ticker?
Natures Sunshine Products Inc trades under the ticker NATR on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Natures Sunshine Products Inc's revenue, and how fast is it growing?
Over its most recent trailing twelve months, Natures Sunshine Products Inc reported revenue of $492M, 6.8% higher than a year earlier, according to its SEC filings.
What is Natures Sunshine Products Inc's free cash flow?
Natures Sunshine Products Inc's free-cash-flow margin is 3.7% of revenue over the trailing twelve months, ranking 14 of the 21 personal care products companies we cover.
What is Natures Sunshine Products Inc's fair value (intrinsic value) per share?
Our discounted-cash-flow model of Natures Sunshine Products Inc's free cash flow after stock-based pay gives ~$20 per share in the base case, and ~$16–$25 across growth scenarios. These are model values under stated assumptions — not a price target or a recommendation.
Who are Natures Sunshine Products Inc's largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Wynnefield Capital Inc, Prescott Group Capital Management, L.L.C. and Blackrock, Inc. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Natures Sunshine Products Inc buying back stock, and does it pay a dividend?
Natures Sunshine Products Inc spent $6.5M on share repurchases over the trailing twelve months, and its diluted share count fell 4.6% over the year.
What is Natures Sunshine Products Inc's market cap?
On November 2, 2026, Natures Sunshine Products Inc's market capitalisation was about $217M, with a price-to-earnings ratio of 12.0 and net debt of -$82.5M. Market figures come from third-party market data and may be delayed.
Who are Natures Sunshine Products Inc's competitors?
In our Personal Care Products peer group, the companies closest to Natures Sunshine Products Inc are Honest Company, Inc., Oddity Tech Ltd, Usana Health Sciences Inc, Lifevantage Corp and NU Skin Enterprises, Inc. The side-by-side comparison below sets their revenue, margins and growth against Natures Sunshine Products Inc's.
Are insiders buying or selling Natures Sunshine Products Inc stock?
Over the last 12 months, Natures Sunshine Products Inc's directors and officers reported 14 open-market purchases and 12 sales on Form 4. The insider trading page charts every trade.
When is Natures Sunshine Products Inc's next earnings date?
Around November 4, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Natures Sunshine Products Inc announces its own schedule.